These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4929888)

  • 1. [Recent acquisitions in the study of the pharmacology of natural cardiotonics. I. Biotransformation].
    Lesne M
    J Pharm Belg; 1970; 25(2):83-105. PubMed ID: 4929888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution and biotransformation of various cardiac glycosides].
    Lüllmann H; Peters T; Seiler KU
    Dtsch Med Wochenschr; 1971 Jun; 96(23):1018-21. PubMed ID: 4932862
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the pharmacokinetics of peruvoside. II. Comparative studies with H3-ouabain and H3-digitoxin in guinea pigs].
    Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1597-601. PubMed ID: 5756472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the blood level and secretion of radioactively labeled cardiac glycosides following intraduodenal application in the cat].
    Lahrtz H; Sattler RW; van Zwieten PA
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):210-22. PubMed ID: 5728874
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple approach to follow the metabolic degradation of cardiac glycosides in vivo.
    Glover A; Kokenge F; Lüllmann H; Peters T; Seiler KU; van Zweiten PA
    Klin Wochenschr; 1971 Oct; 49(19):1062-5. PubMed ID: 5115325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism and intestinal absorption of cardiac glycosides].
    Lauterbach F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199
    [No Abstract]   [Full Text] [Related]  

  • 9. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion of cardiac glycosides.
    Russell JQ; Klaassen CD
    J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic degradation of 3H-labelled cardiac glycosides by the isolated perfused guinea pig liver].
    Kolenda KD; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):374-5. PubMed ID: 4253809
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the determination of cardiotoxicity of cardiac glycosides in cats. 1. General bases and biophysical model for intravenous and intraduodenal infusion experiments].
    Lenke D; Schneider B
    Arzneimittelforschung; 1969 May; 19(5):687-93. PubMed ID: 5819774
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the problem of cardiac glycoside accumulation].
    Kuschinsky K
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2344-7. PubMed ID: 4881347
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent aspects of therapy with cardiac glycosides].
    Bayer O; Jost F
    Dtsch Med J; 1970 May; 21(10):675-6 passim. PubMed ID: 5523167
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue distribution, metabolism and elimination of cardiac glycosides.
    van Zwieten PA
    Ger Med Mon; 1968 Jul; 13(7):346-9. PubMed ID: 4879650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical principles of the development of new cardiac drugs of the digitalis type].
    Repke KR
    Pharmazie; 1972 Nov; 27(11):693-701. PubMed ID: 4265944
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elimination of cardiac glycosides by hemofiltration].
    Kramer P; Matthias C; Matthaei D; Scheler F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1618-21. PubMed ID: 611892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic studies on helveticosol acetonide in man].
    Zielske F; Dovidat H; Betzien G; Voigtländer W
    Arzneimittelforschung; 1971 Apr; 21(4):566-71. PubMed ID: 5108163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Directed glycoside therapy of manifest heart insufficiency].
    Storz H
    Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.